However, combined inhibition of WEE1 and ATR appeared to reduce cell viability to a different extent in the four lung cancer cell lines, showing more than additive effects in H460, H1975, and SW900, but little synergy in A549 (Figure 4A and Figure S5A and Table S1). The gene discussed is ATR; the disease is lung cancer.